Frontlight ResearchEarly access
Trial site
Yeungnam Univeristy Medical Center
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Obesity4 trials
- Ulcerative colitis2 trials
- Chronic kidney disease1 trial
- COPD1 trial
- Crohn's disease1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Status
- Completed3 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company10 trials
Running trials
Not yet recruiting
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Type 2 diabetes2 recruiting
- COPD1 recruiting
- Metastatic breast cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026